| Authors: |
Greveling M; Department of Rheumatology & Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands., Rodolfi S; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital and University College London, London, UK., El Bardai N; Department of Rheumatology & Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands., Denton CP; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital and University College London, London, UK., Ong VH; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital and University College London, London, UK., Jeffries-Owen N; Scleroderma & Raynaud's UK (SRUK), London, United Kingdom., Schriemer R; National Association for People with Lupus, Systemic Sclerosis, Antiphospholipid Syndrome, and Mixed Connective Tissue Disease (NVLE), Utrecht, The Netherlands., Tweehuysen L; Department of Rheumatology & Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands., Spierings J; Department of Rheumatology & Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital and University College London, London, UK. |
